Belzutifan


In the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery.
We can provide high-quality Belzutifan and its derived impurities.
  • CAS
    1672668-24-4
  • Catalog
    HY-125840
  • Molecular Weight
    383.34
  • Molecular Formular
    C17H12F3NO4S

Request for Information

  • Please enter Catalog.
    Please enter CAS.
  • Please enter first Name.
    Please enter last Name.
  • Please enter email address.
  • Please enter company address.
    Please enter the correct captcha.
Please check agree.